EVERUS CONSTRUCTION GROUP (ECG) Fundamental Analysis & Valuation

NYSE:ECG • US3004261034

110.25 USD
-1.71 (-1.53%)
At close: Mar 6, 2026
110.25 USD
0 (0%)
After Hours: 3/6/2026, 8:13:34 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This ECG fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

6

Taking everything into account, ECG scores 6 out of 10 in our fundamental rating. ECG was compared to 55 industry peers in the Construction & Engineering industry. ECG scores excellent points on both the profitability and health parts. This is a solid base for a good stock. ECG is quite expensive at the moment. It does show a decent growth rate. These ratings could make ECG a good candidate for quality investing.


Dividend Valuation Growth Profitability Health

7

1. ECG Profitability Analysis

1.1 Basic Checks

  • In the past year ECG was profitable.
  • ECG had a positive operating cash flow in the past year.
  • In the past 5 years ECG has always been profitable.
  • ECG had a positive operating cash flow in 4 of the past 5 years.
ECG Yearly Net Income VS EBIT VS OCF VS FCFECG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 2025 0 100M 200M

1.2 Ratios

  • ECG has a Return On Assets of 11.67%. This is amongst the best in the industry. ECG outperforms 85.45% of its industry peers.
  • Looking at the Return On Equity, with a value of 32.04%, ECG belongs to the top of the industry, outperforming 83.64% of the companies in the same industry.
  • ECG has a Return On Invested Capital of 19.28%. This is in the better half of the industry: ECG outperforms 80.00% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for ECG is above the industry average of 17.17%.
Industry RankSector Rank
ROA 11.67%
ROE 32.04%
ROIC 19.28%
ROA(3y)11.95%
ROA(5y)N/A
ROE(3y)32.18%
ROE(5y)N/A
ROIC(3y)19.3%
ROIC(5y)N/A
ECG Yearly ROA, ROE, ROICECG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 2025 10 20 30

1.3 Margins

  • With a decent Profit Margin value of 5.39%, ECG is doing good in the industry, outperforming 63.64% of the companies in the same industry.
  • ECG's Profit Margin has improved in the last couple of years.
  • With a Operating Margin value of 7.07%, ECG perfoms like the industry average, outperforming 54.55% of the companies in the same industry.
  • ECG's Operating Margin has improved in the last couple of years.
  • The Gross Margin of ECG (12.12%) is worse than 67.27% of its industry peers.
  • ECG's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 7.07%
PM (TTM) 5.39%
GM 12.12%
OM growth 3Y5.03%
OM growth 5YN/A
PM growth 3Y5.22%
PM growth 5YN/A
GM growth 3Y5.83%
GM growth 5YN/A
ECG Yearly Profit, Operating, Gross MarginsECG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 2025 2 4 6 8 10

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. ECG Health Analysis

2.1 Basic Checks

  • ECG has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
  • ECG has about the same amout of shares outstanding than it did 1 year ago.
  • Compared to 1 year ago, ECG has an improved debt to assets ratio.
ECG Yearly Shares OutstandingECG Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 2025 10M 20M 30M 40M 50M
ECG Yearly Total Debt VS Total AssetsECG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 2025 500M 1B 1.5B

2.2 Solvency

  • ECG has an Altman-Z score of 6.57. This indicates that ECG is financially healthy and has little risk of bankruptcy at the moment.
  • ECG's Altman-Z score of 6.57 is amongst the best of the industry. ECG outperforms 81.82% of its industry peers.
  • The Debt to FCF ratio of ECG is 3.13, which is a good value as it means it would take ECG, 3.13 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 3.13, ECG is in the better half of the industry, outperforming 76.36% of the companies in the same industry.
  • A Debt/Equity ratio of 0.42 indicates that ECG is not too dependend on debt financing.
  • ECG's Debt to Equity ratio of 0.42 is in line compared to the rest of the industry. ECG outperforms 58.18% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.42
Debt/FCF 3.13
Altman-Z 6.57
ROIC/WACC1.93
WACC9.99%
ECG Yearly LT Debt VS Equity VS FCFECG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 2025 0 200M 400M 600M

2.3 Liquidity

  • ECG has a Current Ratio of 1.76. This is a normal value and indicates that ECG is financially healthy and should not expect problems in meeting its short term obligations.
  • ECG's Current ratio of 1.76 is fine compared to the rest of the industry. ECG outperforms 80.00% of its industry peers.
  • ECG has a Quick Ratio of 1.70. This is a normal value and indicates that ECG is financially healthy and should not expect problems in meeting its short term obligations.
  • With an excellent Quick ratio value of 1.70, ECG belongs to the best of the industry, outperforming 85.45% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.76
Quick Ratio 1.7
ECG Yearly Current Assets VS Current LiabilitesECG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 2025 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. ECG Growth Analysis

3.1 Past

  • ECG shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 40.52%, which is quite impressive.
  • Measured over the past years, ECG shows a quite strong growth in Earnings Per Share. The EPS has been growing by 17.26% on average per year.
  • Looking at the last year, ECG shows a very strong growth in Revenue. The Revenue has grown by 31.47%.
  • Measured over the past years, ECG shows a quite strong growth in Revenue. The Revenue has been growing by 11.55% on average per year.
EPS 1Y (TTM)40.52%
EPS 3Y17.26%
EPS 5YN/A
EPS Q2Q%61.19%
Revenue 1Y (TTM)31.47%
Revenue growth 3Y11.55%
Revenue growth 5YN/A
Sales Q2Q%33.15%

3.2 Future

  • Based on estimates for the next years, ECG will show a small growth in Earnings Per Share. The EPS will grow by 7.99% on average per year.
  • Based on estimates for the next years, ECG will show a small growth in Revenue. The Revenue will grow by 5.45% on average per year.
EPS Next Y6.51%
EPS Next 2Y9.26%
EPS Next 3Y11.45%
EPS Next 5Y7.99%
Revenue Next Year15.27%
Revenue Next 2Y11.96%
Revenue Next 3Y11.57%
Revenue Next 5Y5.45%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ECG Yearly Revenue VS EstimatesECG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B 4B 5B
ECG Yearly EPS VS EstimatesECG Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 2028 2029 2030 1 2 3 4 5

More info and screens

Find the best growth stocksShow best growing peers

3

4. ECG Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 27.98, which means the current valuation is very expensive for ECG.
  • Based on the Price/Earnings ratio, ECG is valued a bit cheaper than the industry average as 69.09% of the companies are valued more expensively.
  • ECG's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 26.29.
  • With a Price/Forward Earnings ratio of 26.27, ECG can be considered very expensive at the moment.
  • 61.82% of the companies in the same industry are more expensive than ECG, based on the Price/Forward Earnings ratio.
  • ECG's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 24.57.
Industry RankSector Rank
PE 27.98
Fwd PE 26.27
ECG Price Earnings VS Forward Price EarningsECG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • ECG's Enterprise Value to EBITDA is on the same level as the industry average.
  • ECG's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 62.48
EV/EBITDA 19.83
ECG Per share dataECG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ECG does not grow enough to justify the current Price/Earnings ratio.
  • ECG has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)4.3
PEG (5Y)N/A
EPS Next 2Y9.26%
EPS Next 3Y11.45%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ECG Dividend Analysis

5.1 Amount

  • No dividends for ECG!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ECG Fundamentals: All Metrics, Ratios and Statistics

EVERUS CONSTRUCTION GROUP

NYSE:ECG (3/6/2026, 8:13:34 PM)

After market: 110.25 0 (0%)

110.25

-1.71 (-1.53%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)02-24
Earnings (Next)05-11
Inst Owners86.38%
Inst Owner Change4.71%
Ins Owners0.3%
Ins Owner Change0.15%
Market Cap5.62B
Revenue(TTM)3.75B
Net Income(TTM)201.77M
Analysts76.36
Price Target106.28 (-3.6%)
Short Float %4.15%
Short Ratio3.01
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)58.53%
Min EPS beat(2)39.23%
Max EPS beat(2)77.83%
EPS beat(4)4
Avg EPS beat(4)63.8%
Min EPS beat(4)39.23%
Max EPS beat(4)77.83%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)15.74%
Min Revenue beat(2)13.86%
Max Revenue beat(2)17.63%
Revenue beat(4)4
Avg Revenue beat(4)19.01%
Min Revenue beat(4)13.86%
Max Revenue beat(4)23.55%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.39%
PT rev (3m)-1.39%
EPS NQ rev (1m)0%
EPS NQ rev (3m)5.21%
EPS NY rev (1m)0.8%
EPS NY rev (3m)23.61%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.82%
Revenue NY rev (1m)0.36%
Revenue NY rev (3m)7.01%
Valuation
Industry RankSector Rank
PE 27.98
Fwd PE 26.27
P/S 1.5
P/FCF 62.48
P/OCF 35.86
P/B 8.93
P/tB 11.56
EV/EBITDA 19.83
EPS(TTM)3.94
EY3.57%
EPS(NY)4.2
Fwd EY3.81%
FCF(TTM)1.76
FCFY1.6%
OCF(TTM)3.07
OCFY2.79%
SpS73.44
BVpS12.35
TBVpS9.54
PEG (NY)4.3
PEG (5Y)N/A
Graham Number33.08
Profitability
Industry RankSector Rank
ROA 11.67%
ROE 32.04%
ROCE 26.67%
ROIC 19.28%
ROICexc 23.28%
ROICexgc 28.19%
OM 7.07%
PM (TTM) 5.39%
GM 12.12%
FCFM 2.4%
ROA(3y)11.95%
ROA(5y)N/A
ROE(3y)32.18%
ROE(5y)N/A
ROIC(3y)19.3%
ROIC(5y)N/A
ROICexc(3y)21.39%
ROICexc(5y)N/A
ROICexgc(3y)26.75%
ROICexgc(5y)N/A
ROCE(3y)26.71%
ROCE(5y)N/A
ROICexgc growth 3Y6.67%
ROICexgc growth 5YN/A
ROICexc growth 3Y8.88%
ROICexc growth 5YN/A
OM growth 3Y5.03%
OM growth 5YN/A
PM growth 3Y5.22%
PM growth 5YN/A
GM growth 3Y5.83%
GM growth 5YN/A
F-Score5
Asset Turnover2.17
Health
Industry RankSector Rank
Debt/Equity 0.42
Debt/FCF 3.13
Debt/EBITDA 0.91
Cap/Depr 232.07%
Cap/Sales 1.78%
Interest Coverage 13.43
Cash Conversion 53.43%
Profit Quality 44.61%
Current Ratio 1.76
Quick Ratio 1.7
Altman-Z 6.57
F-Score5
WACC9.99%
ROIC/WACC1.93
Cap/Depr(3y)192.28%
Cap/Depr(5y)175.68%
Cap/Sales(3y)1.58%
Cap/Sales(5y)1.48%
Profit Quality(3y)74.59%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)40.52%
EPS 3Y17.26%
EPS 5YN/A
EPS Q2Q%61.19%
EPS Next Y6.51%
EPS Next 2Y9.26%
EPS Next 3Y11.45%
EPS Next 5Y7.99%
Revenue 1Y (TTM)31.47%
Revenue growth 3Y11.55%
Revenue growth 5YN/A
Sales Q2Q%33.15%
Revenue Next Year15.27%
Revenue Next 2Y11.96%
Revenue Next 3Y11.57%
Revenue Next 5Y5.45%
EBIT growth 1Y39.41%
EBIT growth 3Y17.16%
EBIT growth 5YN/A
EBIT Next Year32.65%
EBIT Next 3Y20.44%
EBIT Next 5Y16.39%
FCF growth 1Y-21.8%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-4%
OCF growth 3YN/A
OCF growth 5YN/A

EVERUS CONSTRUCTION GROUP / ECG FAQ

Can you provide the ChartMill fundamental rating for EVERUS CONSTRUCTION GROUP?

ChartMill assigns a fundamental rating of 6 / 10 to ECG.


What is the valuation status for ECG stock?

ChartMill assigns a valuation rating of 3 / 10 to EVERUS CONSTRUCTION GROUP (ECG). This can be considered as Overvalued.


How profitable is EVERUS CONSTRUCTION GROUP (ECG) stock?

EVERUS CONSTRUCTION GROUP (ECG) has a profitability rating of 7 / 10.


What is the valuation of EVERUS CONSTRUCTION GROUP based on its PE and PB ratios?

The Price/Earnings (PE) ratio for EVERUS CONSTRUCTION GROUP (ECG) is 27.98 and the Price/Book (PB) ratio is 8.93.


What is the expected EPS growth for EVERUS CONSTRUCTION GROUP (ECG) stock?

The Earnings per Share (EPS) of EVERUS CONSTRUCTION GROUP (ECG) is expected to grow by 6.51% in the next year.